Schneiderhan 2014.

Methods	Randomised trial
Participants	121 participants (intervention 61: control 60) Metabolic syndrome/psychotic 3 community mental health clinic setting Minnesota, USA Year of study: February 2012 to January 2014
Interventions	Pharmacist comprehensive medication management not described
Outcomes	Taking antipsychotic medicines
Notes	Funding source: Founded by Medica Foundation, Minneaplois, Minnesota and Peters Institute of Pharmaceutical Care, College of Pharmacy, University of Minnesota, Minneapolis Conflict of interest: Dr Scheniiderhan has received honoraria from the American Society of Health System Pharmacists.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Quote: "a block randomization schedule was used to ensure balanced treatment assignment of subjects recruited at each site"
Allocation concealment (selection bias)	Low risk	Quote: "a block randomization schedule was used to ensure balanced treatment assignment of subjects recruited at each site" A centralised call‐in system was used to inform the investigators of the participant’s random group assignment
Blinding of participants and personnel (performance bias) All Outcomes/Outcome 1	Unclear risk	Intervention unclear
Blinding of outcome assessment (detection bias) All Outcomes/Outcome 1	Unclear risk	Unclear who collected data; blinding unclear
Incomplete outcome data (attrition bias) All outcomes	High risk	Between group attrition < 10%, however, overall attrition rate >20%.
Selective reporting (reporting bias)	Low risk	All reported
Other bias	Low risk	None